Notably, upregulation of exhaustion markers like IL10, LAG3, CD27, FAS, CD8B occur in early-stage CRC (stage II) as well as late stages (stage III and stage IV) indicating that immune suppression mechanisms exist even in early stages of CRC. The gene discussed is LAG3; the disease is colorectal carcinoma.